ExodusPoint Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-18,807
| Closed | -$6.59M | – | 1689 |
|
|
2025
Q4 | $6.59M | Buy |
+18,807
| New | +$6.36M | 0.05% | 380 |
|
|
2025
Q3 | – | Sell |
-22,440
| Closed | -$8.73M | – | 1666 |
|
|
2025
Q2 | $8.73M | Buy |
+22,440
| New | +$9.03M | 0.08% | 267 |
|
|
2025
Q1 | – | Sell |
-13,587
| Closed | -$5.01M | – | 1603 |
|
|
2024
Q4 | $5.01M | Sell |
13,587
-73,591
| -84% | -$30.8M | 0.03% | 442 |
|
|
2024
Q3 | $45.3M | Buy |
87,178
+47,912
| +122% | +$25.6M | 0.28% | 50 |
|
|
2024
Q2 | $21.3M | Buy |
39,266
+16,057
| +69% | +$8.49M | 0.15% | 121 |
|
|
2024
Q1 | $12M | Buy |
23,209
+13,578
| +141% | +$6.75M | 0.09% | 182 |
|
|
2023
Q4 | $4.54M | Sell |
9,631
-9,221
| -49% | -$4.26M | 0.03% | 365 |
|
|
2023
Q3 | $8.21M | Sell |
18,852
-11,411
| -38% | -$5.18M | 0.08% | 262 |
|
|
2023
Q2 | $13.4M | Buy |
30,263
+12,829
| +74% | +$5.92M | 0.11% | 189 |
|
|
2023
Q1 | $8.02M | Buy |
17,434
+15,150
| +663% | +$7.21M | 0.07% | 356 |
|
|
2022
Q4 | $1.17M | Sell |
2,284
-6,708
| -75% | -$3.41M | 0.02% | 879 |
|
|
2022
Q3 | $4.08M | Buy |
8,992
+1,759
| +24% | +$842K | 0.05% | 478 |
|
|
2022
Q2 | $3.49M | Buy |
+7,233
| New | +$3.58M | 0.04% | 543 |
|
|
2022
Q1 | – | Sell |
-20,775
| Closed | -$9.63M | – | 2309 |
|
|
2021
Q4 | $9.63M | Buy |
+20,775
| New | +$8.74M | 0.1% | 231 |
|
|
2021
Q3 | – | Sell |
-8,408
| Closed | -$3.21M | – | 2245 |
|
|
2021
Q2 | $3.21M | Sell |
8,408
-8,769
| -51% | -$3.35M | 0.04% | 493 |
|
|
2021
Q1 | $6.17M | Sell |
17,177
-2,280
| -12% | -$733K | 0.09% | 216 |
|
|
2020
Q4 | $6.25M | Sell |
19,457
-5,120
| -21% | -$1.57M | 0.06% | 203 |
|
|
2020
Q3 | $6.6M | Buy |
24,577
+11,912
| +94% | +$3.21M | 0.13% | 140 |
|
|
2020
Q2 | $3.33M | Buy |
12,665
+9,375
| +285% | +$2.5M | 0.09% | 260 |
|
|
2020
Q1 | $747K | Buy |
+3,290
| New | +$897K | 0.04% | 365 |
|
|
2019
Q4 | – | Sell |
-7,235
| Closed | -$1.74M | – | 1622 |
|
|
2019
Q3 | $1.74M | Buy |
7,235
+6,353
| +720% | +$1.74M | 0.06% | 268 |
|
|
2019
Q2 | $249K | Sell |
882
-7,192
| -89% | -$1.96M | 0.01% | 794 |
|
|
2019
Q1 | $2.32M | Buy |
8,074
+6,957
| +623% | +$2.01M | 0.17% | 93 |
|
|
2018
Q4 | $293K | Buy |
+1,117
| New | +$307K | 0.02% | 201 |
|
Other funds holding ELV
VCM
VPM
ExodusPoint Capital Management's ELV Position: Q1 2026 in Review
ExodusPoint Capital Management sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 18,807 shares — an estimated $6.59M sold.
ExodusPoint Capital Management first reported a position in ELV in Q4 2018 and held it in 24 quarters. The position peaked at $45.3M in Q3 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- ExodusPoint Capital Management reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
- ExodusPoint Capital Management sold 18,807 Elevance Health shares in Q1 2026, an estimated $6.59M.
- ExodusPoint Capital Management first reported a position in Elevance Health in Q4 2018 and held it in 24 quarters.
- ExodusPoint Capital Management's Elevance Health position peaked at $45.3M in Q3 2024.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.